Verorab

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

2 competitors in Amnesia

#DrugCompanyPhaseTrials

1

Crestor

AstraZeneca

Approved

—2

Versed

CConrado Roberto Hoffmann Filho

Approved

—3

Verorab

Sinovac Biotech Co., Ltd

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Immunogenicity3 trials

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Not yet recruiting·Sinovac Biotech Co., Ltd·Phase 3·NCT07055893·390 enrolled

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Not yet recruiting·Sinovac Biotech Co., Ltd·Phase 3·NCT07055295·390 enrolled

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Not yet recruiting·Sinovac Biotech Co., Ltd·Phase 2·NCT07055880·120 enrolled

Malaria2 trials

Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country

Completed·SSwiss Tropical & Public Health Institute·Phase 1·NCT05644067·40 enrolled

A Randomised Phase Ib Trial to Assess the Blood-stage Efficacy of SUM-101 Malaria Vaccine in Adults Residing in Malaria-endemic Settings, After Controlled Human Malaria Infection Using 3D7 P. Falciparum Blood-stage Malaria Infection

Withdrawn·EEuropean Vaccine Initiative·Phase 1·NCT07124156

Amnesia1 trial

Investigation of Immune Amnesia Following Measles Infection in Select African Regions

Active, not recruiting·NNational Institute of Allergy and Infectious Diseases (NIAID)··NCT06153979·256 enrolled

Immunization1 trial

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Unknown status·—·Phase 4·NCT02490956·40 enrolled

Details

Drug Info

Related News